Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-24 @ 11:32 PM
NCT ID:
NCT02648256
Eligibility Criteria:
Inclusion Criteria:
* Age over 18 years
* Clinical or radiological indication for a broncho-alveolar lavage to search infectious agents including Pneumocystis jirovecii
* Patients with risk factors for developing a Pneumocystis jirovecii pneumonia : underlying malignancy (solid cancer, hematologic disease), organ transplant or hematopoietic stem cells, autoimmune disease or chronic inflammatory disease justifying immunosuppressive therapy (chemotherapy anticancer, immunomodulatory, biotherapy, corticosteroids) or patient treated with corticosteroids for more than a month or congenital immune deficiency or other causes of immunosuppression (excluding human immunodeficiency virus) at the discretion of the clinician,
* Informed consent given.
Exclusion Criteria:
* Patient human immunodeficiency virus positive
* Contraindication to the achievement of broncho-alveolar lavage,
* Contraindication to the achievement of a Oropharyngeal rinse (disorder of consciousness, swallowing disorder),
* Prophylaxis with cotrimoxazole or aerosol pentamidine,
* Empirical curative treatment with cotrimoxazole or other curative therapeutic alternative (pentamidine, atovaquone, dapsone, clindamycin-primaquine) started for more than 48 hours,
* Major person under legal protection (backup justice, trusteeship, guardianship), person deprived of liberty.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02648256
Study Brief:
Protocol Section:
NCT02648256